World's Best Scientists 2026 revealed!
VIEW LIST
Brian I. Rini

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 130 2439 2271 1381 1266 1002 88599

Brian I. Rini publications per year

The chart shows the history of publications by Brian I. Rini between 1995 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Brian I. Rini published across 32 years, from 1995 to 2026, averaging 41.6 papers a year. Output peaked at 187 publications in 2023. 52 of the 1,330 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1995 to 2026. Vertical axis: number of publications, 0 to 187. Peak 187 publications in 2023. 1995: 1 publication 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 3 publications 2000: 4 publications 2001: 3 publications 2002: 6 publications 2003: 3 publications 2004: 16 publications 2005: 20 publications 2006: 34 publications 2007: 42 publications 2008: 43 publications 2009: 45 publications 2010: 28 publications 2011: 51 publications 2012: 62 publications 2013: 45 publications 2014: 56 publications 2015: 65 publications 2016: 62 publications 2017: 76 publications 2018: 74 publications 2019: 63 publications 2020: 79 publications 2021: 76 publications 2022: 39 publications 2023: 187 publications 2024: 95 publications 2025: 45 publications 2026: 7 publications
1995 2026

1,330 publications in total across all disciplines

View publications per year as a table
Brian I. Rini: publications per year, 1995 to 2026
Year Publications
1995 1
1996 0
1997 0
1998 0
1999 3
2000 4
2001 3
2002 6
2003 3
2004 16
2005 20
2006 34
2007 42
2008 43
2009 45
2010 28
2011 51
2012 62
2013 45
2014 56
2015 65
2016 62
2017 76
2018 74
2019 63
2020 79
2021 76
2022 39
2023 187
2024 95
2025 45
2026 7
Total 1,330
Download as CSV

Brian I. Rini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brian I. Rini sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,001–1,020 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,002 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77 1,002
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Brian I. Rini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brian I. Rini sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 130–131 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 130 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179 130
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Brian I. Rini is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily addresses the treatment and biology of renal cell carcinoma and related cancers, contributing to both clinical and molecular understanding within the oncology field.

Their publication record includes numerous works in leading medical and oncology journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Urology
  • The Oncologist
  • ESMO Open

Their main fields of study encompass Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, their subfields cover Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research, and Economics and Econometrics.

Brian I. Rini's research topics focus strongly on:

  • Renal cell carcinoma treatment
  • Cancer Immunotherapy and Biomarkers
  • Renal and related cancers
  • Cancer Genomics and Diagnostics
  • Economic and Financial Impacts of Cancer
  • Pancreatic and Hepatic Oncology Research
  • Bladder and Urothelial Cancer Treatments

Recent papers reflect areas at the intersection of clinical oncology and immunotherapy. Notable publications include:

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, 2020, The Lancet
  • Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial, 2020, The Lancet Oncology
  • Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial, 2020, ESMO Open
  • Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade, 2020, Cancer Cell
  • The immunology of renal cell carcinoma, 2020, Nature Reviews Nephrology

Collaborations have been an integral part of their work, frequently co-authoring with researchers such as Toni K. Choueiri, Laurence Albigès, Robert J. Motzer, David F. McDermott, and Michael B. Atkins. These co-authors are prominent within oncology and related biomedical research, underlining a network focused on cancer treatment and translational studies.

Best Publications

  • Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

    Robert J Motzer;Nizar M Tannir;David F McDermott;Osvaldo Arén Frontera

  • Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    Brian I. Rini;Elizabeth R. Plimack;Viktor Stus;Rustem Gafanov

  • Renal cell carcinoma

    Brian I Rini;Steven C Campbell;Bernard Escudier

  • Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;M. Dror Michaelson;Bruce G. Redman;Gary R. Hudes

  • Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    Robert J. Motzer;Konstantin Penkov;John Haanen;Brian Rini

  • Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

    Brian I. Rini;Bernard Escudier;Piotr Tomczak;Andrey Kaprin

  • Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

    Daniel Y.C. Heng;Wanling Xie;Meredith M. Regan;Mark A. Warren

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Sunitinib in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Brian I. Rini;Brian I. Rini;Ronald M. Bukowski;Brendan D. Curti

  • Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

    Toni K. Choueiri;Bernard Escudier;Thomas Powles;Paul N. Mainwaring

  • Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

    Robert J. Motzer;Brian I. Rini;David F. McDermott;Bruce G. Redman

  • Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

    Brian I Rini;Thomas Powles;Michael B Atkins;Bernard Escudier

  • Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

    Brian I Rini;Susan Halabi;Jonathan E. Rosenberg;Walter M. Stadler

  • Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

    David F. McDermott;Mahrukh A. Huseni;Michael B. Atkins;Robert J. Motzer

  • External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

    Daniel Y.C. Heng;Wanling Xie;Meredith M. Regan;Lauren C. Harshman

  • Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

    Jennifer S. Ko;Arnold H. Zea;Brian I. Rini;Joanna L. Ireland

  • Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

    Toni K Choueiri;Bernard Escudier;Thomas Powles;Nizar M Tannir

  • Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

    Brian I. Rini;Susan Halabi;Jonathan E. Rosenberg;Walter M. Stadler

  • Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

    Robert J Motzer;Bernard Escudier;Piotr Tomczak;Thomas E Hutson

  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    Robert J. Motzer;Brian I. Rini;David F. McDermott;Osvaldo Arén Frontera

Frequent Co-Authors

Toni K. Choueiri
Toni K. Choueiri Harvard University
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
Thomas Powles
Thomas Powles Queen Mary University of London
Michael B. Atkins
Michael B. Atkins Georgetown University
James H. Finke
James H. Finke Cleveland Clinic Lerner College of Medicine
Ronald M. Bukowski
Ronald M. Bukowski Cleveland Clinic
Elizabeth R. Plimack
Elizabeth R. Plimack Fox Chase Cancer Center
Steven C. Campbell
Steven C. Campbell Cleveland Clinic

External Links

Personal website of Brian I. Rini

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering Medicine in the USA, there are multiple online degree options and career pathways to explore. Those already working as registered nurses might look into rn to bsn programs without clinicals. These programs are designed for flexibility, letting nurses advance their education without traditional in-person requirements.

For those interested in advancing further, doctoral nursing pathways offer accelerated options. The shortest dnp programs provide a streamlined route for qualified nurses to earn their Doctor of Nursing Practice in less time. Some students may also prefer easiest dnp programs, which focus on user-friendly curricula and manageable workloads.

If you’re just beginning your journey, consider starting with a fast lpn program. These online courses help students become Licensed Practical Nurses quickly, offering a stepping stone to further medical education and employment.

Exploring these varied online programs can help you find a pathway that suits your goals, schedule, and learning preferences as you pursue a career in medicine.

Best Scientists Citing Brian I. Rini

Toni K. Choueiri

Toni K. Choueiri

Harvard University

Publications: 234

Bernard Escudier

Bernard Escudier

Institut Gustave Roussy

Publications: 191

Robert J. Motzer

Robert J. Motzer

Memorial Sloan Kettering Cancer Center

Publications: 167

Camillo Porta

Camillo Porta

University of Bari Aldo Moro

Publications: 144

Thomas Powles

Thomas Powles

Queen Mary University of London

Publications: 116

Laurence Albiges

Laurence Albiges

Institut Gustave Roussy

Publications: 112

Nizar M. Tannir

Nizar M. Tannir

The University of Texas MD Anderson Cancer Center

Publications: 101

David F. McDermott

David F. McDermott

Beth Israel Deaconess Medical Center

Publications: 101

Alain Ravaud

Alain Ravaud

University of Bordeaux

Publications: 100

Christopher G. Wood

Christopher G. Wood

The University of Texas MD Anderson Cancer Center

Publications: 89

James Larkin

James Larkin

Royal Marsden NHS Foundation Trust

Publications: 89

Eric Jonasch

Eric Jonasch

The University of Texas MD Anderson Cancer Center

Publications: 89

Sabina Signoretti

Sabina Signoretti

Brigham and Women's Hospital

Publications: 84

Joaquim Bellmunt

Joaquim Bellmunt

Beth Israel Deaconess Medical Center

Publications: 83

Daniel J. George

Daniel J. George

Duke University

Publications: 74

Thomas E. Hutson

Thomas E. Hutson

Texas Oncology

Publications: 73

Trending Scientists

Wen-li Wu

Wen-li Wu

National Institute of Standards and Technology

Claire M. Fraser

Claire M. Fraser

University of Maryland, Baltimore

Weihua Gui

Weihua Gui

Central South University

Eric E. Mamajek

Eric E. Mamajek

California Institute of Technology

Harry Charbonneau

Harry Charbonneau

Purdue University West Lafayette

Fumio Tatsuoka

Fumio Tatsuoka

Tokyo University of Science

Giulio C. Spagnoli

Giulio C. Spagnoli

University Hospital of Basel

Lise Appels

Lise Appels

KU Leuven

Jalal Al-Muhtadi

Jalal Al-Muhtadi

King Saud University

Evangelos A. Theodorou

Evangelos A. Theodorou

Georgia Institute of Technology

Michael Bowker

Michael Bowker

Cardiff University

Eoin O'Brien

Eoin O'Brien

University College Dublin

Michael Koss

Michael Koss

ETH Zurich

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Samantha L. L. Hill

Samantha L. L. Hill

World Conservation Monitoring Centre

Raymundo Arroyave

Raymundo Arroyave

Texas A&M University

Related Medicine Rankings & Guides

2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs

2027 Fastest Online Adult-Gerontology PCNP Graduate Certificate Programs
2027 Best Online Nursing Programs in Ohio – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Ohio – Accredited RN to BSN Programs
2027 Most Affordable Online DNP Programs

2027 Most Affordable Online DNP Programs
2027 How Much Do Medical Assistant Programs & Certifications Cost?

2027 How Much Do Medical Assistant Programs & Certifications Cost?
2027 Cost of LPN Programs & Schools

2027 Cost of LPN Programs & Schools
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Best Online MSN Family Nurse Practitioner Programs

2027 Best Online MSN Family Nurse Practitioner Programs
2027 Most Affordable LPN/LVN to BSN Online Bridge Programs

2027 Most Affordable LPN/LVN to BSN Online Bridge Programs
2027 Best Shortest Online PMHNP Certificate Programs

2027 Best Shortest Online PMHNP Certificate Programs
2027 Is Nursing School Worth It?

2027 Is Nursing School Worth It?
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 How Fast Can I Finish an RN to BSN

2027 How Fast Can I Finish an RN to BSN
2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2027 Most Affordable Online BSN to MSN Bridge Programs

2027 Most Affordable Online BSN to MSN Bridge Programs
2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2027 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Iowa – Accredited RN to BSN Programs
2027 Easiest Nurse Practitioner Specialty Programs to Get Into

2027 Easiest Nurse Practitioner Specialty Programs to Get Into
2027 Most Affordable Online LVN Programs

2027 Most Affordable Online LVN Programs

Recently Published Articles

2027 Which Employers Hire Aviation Management Degree Graduates? Industries, Roles, and Hiring Patterns

2027 Which Employers Hire Aviation Management Degree Graduates? Industries, Roles, and Hiring Patterns
2027 Best LPN Programs in New Mexico – Accredited Online LPN Programs

2027 Best LPN Programs in New Mexico – Accredited Online LPN Programs
2027 How Much Does a Ph.D. Cost?

2027 How Much Does a Ph.D. Cost?
2027 Best LPN Programs in Ohio – Accredited Online LPN Programs

2027 Best LPN Programs in Ohio – Accredited Online LPN Programs
2027 Best Online Marketing Degree Programs

2027 Best Online Marketing Degree Programs
2027 How Many Credits Do You Need for a Criminal Justice Bachelor's Degree?

2027 How Many Credits Do You Need for a Criminal Justice Bachelor's Degree?
2027 How to Become an Elementary Education Teacher: Salary & Career Paths

2027 How to Become an Elementary Education Teacher: Salary & Career Paths
2027 Licensed Professional Clinical Counselor (LPCC) Salary by State

2027 Licensed Professional Clinical Counselor (LPCC) Salary by State
2027 How to Become a History Teacher in Virginia: Requirements & Certification

2027 How to Become a History Teacher in Virginia: Requirements & Certification
2027 Best Value Online Addiction Counseling Degree Programs: Affordable Accredited Options with the Strongest ROI

2027 Best Value Online Addiction Counseling Degree Programs: Affordable Accredited Options with the Strongest ROI
2027 Online Curriculum Design Doctorate Programs for Licensed Professionals

2027 Online Curriculum Design Doctorate Programs for Licensed Professionals
2027 Business Management Careers: Guide to Career Paths, Options & Salary

2027 Business Management Careers: Guide to Career Paths, Options & Salary
2027 AI, Automation, and the Future of Criminology Degree Careers

2027 AI, Automation, and the Future of Criminology Degree Careers
2027 Hardest and Easiest Courses in a Clinical Mental Health Counseling Degree Program

2027 Hardest and Easiest Courses in a Clinical Mental Health Counseling Degree Program
2027 What to Expect From Your First Clinical Placement in SLP Graduate School

2027 What to Expect From Your First Clinical Placement in SLP Graduate School
2027 Cheapest Way to Get a Teaching Credential in Maine: Requirements & Certification

2027 Cheapest Way to Get a Teaching Credential in Maine: Requirements & Certification
2027 Fastest Online Master's in Biotechnology Programs

2027 Fastest Online Master's in Biotechnology Programs
2027 Best ABA Programs in the USA

2027 Best ABA Programs in the USA
2027 Best Online Health Psychology Degree Master's Programs for Working Professionals

2027 Best Online Health Psychology Degree Master's Programs for Working Professionals
2027 Easiest Online Organizational Leadership Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Organizational Leadership Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 Industrial Engineering Degree Programs With No GRE or GMAT Requirements

2027 Industrial Engineering Degree Programs With No GRE or GMAT Requirements